Drug developer GSK is vacating its 635,000-square-foot life sciences lab in Rockville, Maryland, where it was the sole tenant ...

The FTSE 100 index traded up 8.88 points, 0.1%, at 8,786.27. The FTSE 250 was 105.22 points higher, 0.5%, at 21,024.94, and the AIM All-Share rose just 0.34 of a point at 724.88.

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Barclays raises British American Tobacco price target to 3,550 (3,250) pence - 'overweight' Bank of America cuts Rolls-Royce price target to 830 (850) pence - 'buy' Barclays cuts Hiscox price target ...

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...

Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.